IMI rare disease research focusses on gene therapy delivery systems, newborn screening, platform trials for neurofibromatosis and finding a cure for Fibrodysplasia ossificans...
IMI rare disease research focusses on gene therapy delivery systems, newborn screening, platform trials for neurofibromatosis and finding a cure for Fibrodysplasia ossificans...
Many people with diabetes experience hypoglycaemia, when blood sugar levels become too low. IMI project Hypo-RESOLVE is shedding new light on the condition.
The European Medicines Agency issued a third letter of support for the development of new biomarkers and clinical endpoints for a condition that blurs vision and can lead to...
IHI call 3 is a single-stage call with topics on diseases of unmet public health need, rare diseases, mental health, hospital efficiencies, and patient-generated evidence.
The GREG project plans to advance the use of real-world data and evidence in the development and evaluation of medicines and medical devices.
The EMA’s Committee for Medicinal Products for Human Use recommendation for marketing authorisation means we are one step closer to treating adult patients with complicated intra...